Efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus and established cardiovascular disease using insulin: A VERTIS CV substudy

AIM: To assess the efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus (T2DM) and established atherosclerotic cardiovascular disease (ASCVD) inadequately controlled by insulin. MATERIALS AND METHODS: VERTIS CV was the cardiovascular outcome study for ertugliflozin. Patient...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Obes Metab
Main Authors: Lingvay, Ildiko, Greenberg, Michelle, Gallo, Silvina, Shi, Harry, Liu, Jie, Gantz, Ira
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2021
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252001/
https://ncbi.nlm.nih.gov/pubmed/33769675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14385
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares